Body Pharm Client Login

CJC-1295 + Ipamorelin 20

5.0 · 10 verified reviews

A dual growth-hormone secretagogue research formulation combining 10mg CJC-1295 (No-DAC, Modified GRF 1-29) with 10mg Ipamorelin, studied for pulsatile GH release through complementary receptor pathways. Independent HPLC purity testing published per batch. Stored refrigerated at 2–8°C.

99.09%Purity, batch CJIP9837
5.2 mg/mlMeasured concentration
Full lab results and certificate of analysis →
  • Certificates of analysis published for every batch
  • cGMP aseptic fill, ISO 5 laboratory
  • Shipped cold-chain in insulated packaging

Sold for laboratory and research purposes only. Not for human consumption. 18+.

Free guideCJC-1295 & Ipamorelin: the research explained

What clients say

★★★★★

Great service and product and swift customer support

Eid D. · Verified buyer · Jul 2026
★★★★★

Easy ordering and great service! Fantastic

James B. · Verified buyer · Jun 2026
★★★★★

Very informative and helpful pre purchase and post. After care is incredible. Great job, keep it up

Omaad N. · Verified buyer · Jun 2026

About CJC-1295 (No-DAC) + Ipamorelin 20

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). Two variants of CJC-1295 exist in the research literature: CJC-1295 with DAC (Drug Affinity Complex), which covalently binds to albumin and has a half-life of several days; and CJC-1295 without DAC, also called Modified GRF 1-29 or Mod GRF, which carries the stabilising amino-acid substitutions but lacks the albumin-binding modification, giving it a half-life closer to native GHRH (around 30 minutes) and a pulsatile pattern of GH release in research models.

Ipamorelin is a selective pentapeptide ghrelin-receptor agonist (GHSR-1a agonist) that stimulates pulsatile GH release from the anterior pituitary. What distinguishes Ipamorelin in research is its high selectivity - studies consistently document robust GH pulse stimulation with minimal to no significant increase in cortisol, prolactin, or ACTH compared to earlier-generation secretagogues such as GHRP-2 or GHRP-6. This selectivity profile makes it a preferred tool for isolating GH axis effects without confounding hypothalamic-pituitary-adrenal (HPA) axis activation.

The combination of a GHRH analogue (CJC-1295 no-DAC) with a GHSR agonist (Ipamorelin) is studied for its synergistic effect on GH release: CJC-1295 amplifies the signal at the somatotroph level while Ipamorelin provides a separate receptor-mediated pulse trigger.

Additional research applications include sleep architecture studies (GH is predominantly released in slow-wave sleep), post-injury tissue remodelling investigation, and research into the relationship between GH axis function and metabolic rate.

Refrigeration at 2-8°C is required.

For research purposes only. Not approved for human therapeutic use in the UAE or elsewhere.

Specification

Total Content
20mg
Purity
See batch CoA
Storage
2-8°C Refrigerated
Active Ingredient
CJC-1295 (No-DAC) & Ipamorelin
Variant
No-DAC (Modified GRF 1-29)
CJC-1295 (No-DAC) Compound Name
Modified GRF 1-29
CJC-1295 (No-DAC) CAS
863288-34-0
CJC-1295 (No-DAC) MW
~3368 g/mol
Ipamorelin Compound Name
Ipamorelin
Ipamorelin CAS
170851-70-4
Ipamorelin MW
~711.9 g/mol
Verification
HPLC (in-house)

Research areas

Full lab results and certificate of analysis →

Research background

CJC-1295 (No-DAC), or Modified GRF 1-29, is a GHRH analogue with substitutions that resist enzymatic degradation. Lacking the Drug Affinity Complex of the DAC form, it has a short half-life and drives pulsatile, rather than sustained, somatotroph activation, which is why it is studied as a tool for physiological GH pulse dynamics. Ipamorelin is a selective GHSR-1a agonist studied for pulsatile GH release with minimal cortisol, prolactin, or ACTH effect.

Pairing a GHRH analogue with a GHSR-1a agonist is of interest because the two act on distinct receptor pathways; combined exposure has been reported to raise GH pulse amplitude and IGF-1 signalling in rodent models. Supplied for in vitro and laboratory research only.

Read the full guide: CJC-1295 & Ipamorelin: the research explained →

More research compounds

Free research guides

Open to everyone: the research behind each compound, our lab results and how we work.

Why BodyPharm

The standard other suppliers don’t meet

COA testing
Publicly available in-house and third-party certificates with every batch, guaranteed.
ISO 5 facilities
Fully cGMP automated aseptic production line within ISO 5 certified laboratories.
Cold chain
From our labs to yours. Full cold-chain delivery to ensure stability and quality.

Frequently Asked Questions